These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 12093666)

  • 1. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.
    Marmor MF; Carr RE; Easterbrook M; Farjo AA; Mieler WF;
    Ophthalmology; 2002 Jul; 109(7):1377-82. PubMed ID: 12093666
    [No Abstract]   [Full Text] [Related]  

  • 2. New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy.
    Marmor MF
    Arthritis Rheum; 2003 Jun; 48(6):1764. PubMed ID: 12794848
    [No Abstract]   [Full Text] [Related]  

  • 3. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amsler grids for chloroquine toxicity.
    Flach AJ
    Ophthalmology; 2011 Oct; 118(10):2099; author reply 2099-100. PubMed ID: 21968178
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Lyons JS
    Am J Ophthalmol; 2013 Aug; 156(2):410. PubMed ID: 23870365
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for hydroxychloroquine toxicity.
    Pulido JS; Barkmeier AJ; Leavitt JA; Lewis RA
    Ophthalmology; 2012 Jan; 119(1):207; author reply 207-8. PubMed ID: 22214958
    [No Abstract]   [Full Text] [Related]  

  • 8. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
    Aduriz-Lorenzo PM; Aduriz-Llaneza P; Araiz-Iribarren J; Khamashta MA
    Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIMING FOR THE BULL'S EYE: The Cost-Utility of Screening for Hydroxychloroquine Retinopathy.
    McClellan AJ; Chang JS; Smiddy WE
    Retina; 2016 Oct; 36(10):1958-63. PubMed ID: 27465574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine: lean body weight dosing.
    Walvick MD; Walvick MP; Tongson E; Ngo CH
    Ophthalmology; 2011 Oct; 118(10):2100; author reply 2101. PubMed ID: 21968180
    [No Abstract]   [Full Text] [Related]  

  • 11. What is new in recommendations on ophthalmological screening in patients treated with chloroquine and hydroxychloroquine? Update and literature review.
    Wiacek MP; Bobrowska-Snarska D; Lubiński W; Brzosko M; Modrzejewska M
    Niger J Clin Pract; 2017 Aug; 20(8):919-923. PubMed ID: 28891533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and effective screening for hydroxychloroquine toxicity.
    Marmor MF
    Am J Ophthalmol; 2013 Mar; 155(3):413-4. PubMed ID: 23394729
    [No Abstract]   [Full Text] [Related]  

  • 14. RE: Author reply:
    Martínez-Costa L; Trentini FJ; Ibañez MV; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
    Can J Ophthalmol; 2014 Jun; 49(3):308. PubMed ID: 24862783
    [No Abstract]   [Full Text] [Related]  

  • 15. How to set up a Hydroxychloroquine Retinopathy Screening Service.
    Zaidi FH; Rennie CA; Drinkwater AK; Sahu D; Akyol E; Lotery AJ
    Eye (Lond); 2019 Nov; 33(11):1679-1682. PubMed ID: 31028287
    [No Abstract]   [Full Text] [Related]  

  • 16. RE: Microperimetry and the diagnosis of antimalarial maculopathy.
    Easterbrook M
    Can J Ophthalmol; 2014 Jun; 49(3):307-8. PubMed ID: 24862782
    [No Abstract]   [Full Text] [Related]  

  • 17. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply: To PMID 23218706.
    Browning DJ
    Am J Ophthalmol; 2013 Aug; 156(2):410-1. PubMed ID: 23870364
    [No Abstract]   [Full Text] [Related]  

  • 19. [Update on recommendations for screening for hydroxychloroquine retinopathy].
    Couturier A; Giocanti-Aurégan A; Dupas B; Girmens JF; Le Mer Y; Massamba N; Barreau E; Audo I;
    J Fr Ophtalmol; 2017 Nov; 40(9):793-800. PubMed ID: 29054477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ
    Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.